相似文献
1
Preclinical Evaluation of Lipid-Based Nanosystems.
Pharmaceutics. 2021 May 12;13(5):708. doi: 10.3390/pharmaceutics13050708.
2
Editorial-Current Insights on Lipid-Based Nanosystems.
Pharmaceuticals (Basel). 2022 Oct 14;15(10):1267. doi: 10.3390/ph15101267.
3
Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.
Eur J Pharm Sci. 2018 Jan 15;112:159-167. doi: 10.1016/j.ejps.2017.11.023. Epub 2017 Nov 26.
4
Solid lipid nanoparticles and nanostructured lipid carriers--innovative generations of solid lipid carriers.
Curr Drug Deliv. 2008 Oct;5(4):324-31. doi: 10.2174/156720108785915087.
5
Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.
J Control Release. 2004 Mar 5;95(2):217-27. doi: 10.1016/j.jconrel.2003.11.012.
6
Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy.
Int J Pharm. 2006 May 11;314(1):56-62. doi: 10.1016/j.ijpharm.2006.01.022. Epub 2006 Mar 30.
7
Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy.
Pharm Res. 2005 Nov;22(11):1887-97. doi: 10.1007/s11095-005-7148-5.
8
Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation.
Eur J Pharm Biopharm. 2016 Nov;108:235-252. doi: 10.1016/j.ejpb.2016.08.001. Epub 2016 Aug 9.
9
Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data.
Eur J Pharm Biopharm. 2014 May;87(1):1-18. doi: 10.1016/j.ejpb.2014.02.005. Epub 2014 Feb 12.
本文引用的文献
1
Dexamethasone-Loaded Lipomers: Development, Characterization, and Skin Biodistribution Studies.
Pharmaceutics. 2021 Apr 11;13(4):533. doi: 10.3390/pharmaceutics13040533.
2
Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation and In Vivo Studies.
Pharmaceutics. 2021 Apr 9;13(4):523. doi: 10.3390/pharmaceutics13040523.
3
Liposomes to Augment Dialysis in Preclinical Models: A Structured Review.
Pharmaceutics. 2021 Mar 16;13(3):395. doi: 10.3390/pharmaceutics13030395.
4
Cyanocobalamin Ultraflexible Lipid Vesicles: Characterization and In Vitro Evaluation of Drug-Skin Depth Profiles.
Pharmaceutics. 2021 Mar 20;13(3):418. doi: 10.3390/pharmaceutics13030418.
5
Oligonucleotide Delivery across the Caco-2 Monolayer: The Design and Evaluation of Self-Emulsifying Drug Delivery Systems (SEDDS).
Pharmaceutics. 2021 Mar 28;13(4):459. doi: 10.3390/pharmaceutics13040459.
6
The Impact of Lipid Handling and Phase Distribution on the Acoustic Behavior of Microbubbles.
Pharmaceutics. 2021 Jan 19;13(1):119. doi: 10.3390/pharmaceutics13010119.
7
Solid Lipid Particles for Lung Metastasis Treatment.
Pharmaceutics. 2021 Jan 13;13(1):93. doi: 10.3390/pharmaceutics13010093.
8
Oral Gel Loaded by Fluconazole‒Sesame Oil Nanotransfersomes: Development, Optimization, and Assessment of Antifungal Activity.
Pharmaceutics. 2020 Dec 25;13(1):27. doi: 10.3390/pharmaceutics13010027.
9
Nanostructured Lipid Carriers Made of Ω-3 Polyunsaturated Fatty Acids: In Vitro Evaluation of Emerging Nanocarriers to Treat Neurodegenerative Diseases.
Pharmaceutics. 2020 Sep 29;12(10):928. doi: 10.3390/pharmaceutics12100928.
10
Design, Optimization, Manufacture and Characterization of Efavirenz-Loaded Flaxseed Oil Nanoemulsions.
Pharmaceutics. 2020 Aug 23;12(9):797. doi: 10.3390/pharmaceutics12090797.
Zotero 插件